Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Beijing Science Sun Pharmaceutical (300485)
- 11.37
- -0.14-1.22%
Market Closed Apr 24 15:00 CST
5.48BMarket Cap379.00P/E (TTM)
11.56High11.22Low63.31KlotVolume11.56Open11.51Prev Close72.05MTurnover2.31%Turnover Ratio379.00P/E (Static)481.67MShares17.4952wk High1.62P/B3.11BFloat Cap7.9952wk Low13.81Limit Up273.82MShs Float43.34Historical High9.21Limit Down2.95%Range %5.73Historical Low--Dividend TTM11.38Avg Price36.67KlotAsk--Div Yield TTM100Lot Size26.11KlotBid
Beijing Science Sun Pharmaceutical (300485) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.82%404.72M | -4.41%308.63M | -8.40%196.8M | -15.52%92.54M | -12.61%416.48M | -18.01%322.88M | -21.03%214.84M | -17.46%109.54M | -35.12%476.57M | -34.28%393.82M |
| Operating revenue | -2.82%404.72M | -4.41%308.63M | -8.40%196.8M | -15.52%92.54M | -12.61%416.48M | -18.01%322.88M | -21.03%214.84M | -17.46%109.54M | -35.12%476.57M | -34.28%393.82M |
| Other operating revenue | 318.14%6.4M | ---- | 431.16%874.78K | ---- | 136.73%1.53M | ---- | --164.69K | ---- | -20.81%646.39K | ---- |
| Total operating cost | 6.52%416.57M | -0.52%302.55M | -6.99%190.74M | -13.20%90.21M | -24.45%391.08M | -18.60%304.13M | -21.08%205.07M | -20.30%103.93M | -27.15%517.65M | -33.39%373.63M |
| Operating cost | 0.54%141.19M | -3.55%106.3M | -6.34%69.31M | -5.92%34.96M | -0.36%140.43M | -2.20%110.22M | -3.17%74M | -2.40%37.16M | -17.87%140.94M | -18.92%112.7M |
| Operating tax surcharges | 32.70%9.29M | 45.21%6.2M | 31.53%4.79M | 80.67%1.29M | -5.36%7M | -8.86%4.27M | -9.09%3.64M | -18.86%712K | -16.24%7.4M | -41.61%4.68M |
| Operating expense | 2.03%144.47M | -6.47%105.32M | -15.27%65.52M | -30.89%29.94M | -38.55%141.6M | -30.98%112.6M | -30.64%77.33M | -19.90%43.32M | -37.53%230.43M | -44.56%163.16M |
| Administration expense | -7.92%52.96M | -3.06%37.22M | -7.36%23.87M | -11.83%12.19M | -7.52%57.52M | -2.83%38.39M | -0.51%25.77M | 29.89%13.82M | 1.84%62.2M | -2.14%39.51M |
| Financial expense | 49.52%-852.49K | 42.86%-899.2K | 83.88%-79.07K | 81.71%-45.74K | -61.03%-1.69M | -120.91%-1.57M | -43.92%-490.56K | -220.60%-250.07K | -132.38%-1.05M | -130.21%-712.3K |
| -Interest expense (Financial expense) | --454.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | 40.61%-1.01M | 43.11%-901.45K | 81.29%-93.45K | 77.40%-57.23K | -54.54%-1.71M | -108.95%-1.58M | -30.26%-499.36K | -192.01%-253.21K | -127.25%-1.1M | -125.98%-758.35K |
| Research and development | 50.41%69.51M | 20.35%48.4M | 10.08%27.33M | 29.67%11.89M | -40.55%46.22M | -25.92%40.22M | -41.42%24.83M | -65.80%9.17M | -22.76%77.73M | -31.76%54.29M |
| Credit Impairment Loss | -35.89%943.1K | -209.43%-657.96K | -343.86%-1.14M | -172.22%-1.75M | -10.67%1.47M | 378.17%601.24K | 147.80%468.74K | -109.88%-644.12K | 550.35%1.65M | -138.22%-216.15K |
| Asset Impairment Loss | -535.57%-17.77M | ---11.37M | ---- | ---- | ---2.8M | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 122.39%24.27M | 137.97%53.17M | 132.81%45.58M | 119.53%45.05M | -166.57%-108.38M | -171.49%-140.02M | -152.36%-138.92M | -201,417.47%-230.64M | -29.40%162.81M | -19.98%195.87M |
| Fair value change income | 115.23%8.61M | 151.29%44.59M | 142.77%38.54M | 120.51%30.38M | -156.36%-56.51M | -169.70%-86.94M | -153.93%-90.11M | -1,970.60%-148.13M | -20.05%100.27M | -11.96%124.73M |
| Invest income | 155.29%28.54M | 135.20%19.31M | 114.77%7.45M | 119.50%16.18M | -186.31%-51.62M | -177.10%-54.86M | -150.88%-50.45M | -12,408.75%-82.97M | -31.03%59.81M | -21.41%71.15M |
| -Including: Investment income associates | 113.66%8.95M | 114.76%10.47M | 110.69%7.04M | 117.46%15.88M | -239.67%-65.53M | -215.61%-70.92M | -172.24%-65.85M | -2,382.06%-90.93M | -13.35%46.92M | -9.84%61.35M |
| Asset deal income | --111.88K | --111.88K | --111.88K | ---- | ---- | ---- | ---- | ---- | -99.96%2.54K | ---- |
| Other revenue | 256.35%3.83M | 0.92%1.19M | -47.31%614.11K | -77.25%252.18K | -1.46%1.08M | 484.90%1.17M | 1,368.34%1.17M | 1,373.24%1.11M | -90.60%1.09M | -96.66%200.84K |
| Operating profit | 114.96%12.42M | 148.86%59.25M | 139.98%51.64M | 121.05%47.38M | -168.16%-82.97M | -156.13%-121.27M | -146.54%-129.16M | -9,424.25%-225.04M | -52.19%121.74M | -23.67%216.06M |
| Add:Non operating Income | -90.78%34.14K | -89.67%34.14K | -86.73%17.28K | --129.06K | -21.21%370.32K | 965.63%330.63K | 358.86%130.22K | ---- | 721.75%470.02K | -43.97%31.03K |
| Less:Non operating expense | -84.77%146.61K | -84.55%87.56K | ---- | ---- | 2,129.47%962.44K | 3,016.88%566.77K | 52,876.07%526.77K | 1,065.87%1.1K | -44.43%43.17K | -76.59%18.18K |
| Total profit | 114.72%12.3M | 148.72%59.2M | 139.87%51.66M | 121.11%47.5M | -168.41%-83.57M | -156.23%-121.5M | -146.68%-129.56M | -9,329.95%-225.04M | -52.02%122.16M | -23.66%216.07M |
| Less:Income tax cost | 167.45%4.51M | 155.16%10.64M | 127.72%5.9M | 126.18%8.56M | -125.98%-6.69M | -184.68%-19.3M | -176.06%-21.29M | -1,709.22%-32.69M | -50.44%25.76M | -30.66%22.79M |
| Net profit | 110.13%7.79M | 147.50%48.55M | 142.26%45.76M | 120.25%38.94M | -179.74%-76.87M | -152.88%-102.21M | -143.38%-108.26M | -47,421.38%-192.35M | -52.43%96.41M | -22.74%193.29M |
| Net profit from continuing operation | 110.13%7.79M | 147.50%48.55M | 142.26%45.76M | 120.25%38.94M | -179.74%-76.87M | -152.88%-102.21M | -143.38%-108.26M | -47,421.38%-192.35M | -52.43%96.41M | -22.74%193.29M |
| Less:Minority Profit | 15.46%-6.78M | 17.43%-3.31M | 34.73%-2.03M | 40.69%-1.03M | -23.21%-8.02M | -23.70%-4.01M | -46.93%-3.11M | -314.00%-1.73M | -212.23%-6.51M | -32.65%-3.24M |
| Net profit of parent company owners | 121.16%14.57M | 152.81%51.86M | 145.45%47.79M | 120.97%39.97M | -166.90%-68.85M | -149.97%-98.2M | -141.78%-105.15M | -23,235.01%-190.62M | -49.73%102.92M | -22.21%196.53M |
| Earning per share | ||||||||||
| Basic earning per share | 121.43%0.03 | 155.00%0.11 | 145.45%0.1 | 120.98%0.083 | -166.67%-0.14 | -148.78%-0.2 | -142.31%-0.22 | -23,376.47%-0.3957 | -51.16%0.21 | -21.15%0.41 |
| Diluted earning per share | 121.43%0.03 | 155.00%0.11 | 145.45%0.1 | 120.98%0.083 | -166.67%-0.14 | -148.78%-0.2 | -142.31%-0.22 | -23,376.47%-0.3957 | -51.16%0.21 | -21.15%0.41 |
| Other composite income | -231.67%-707.99K | -12.77%-431.25K | -169.36%-153.45K | -185.13%-52.52K | -9.12%537.72K | -135.49%-382.43K | -83.08%221.22K | 113.28%61.7K | -79.89%591.67K | -70.21%1.08M |
| Other composite income of parent company owners | -231.67%-707.99K | -12.77%-431.25K | -169.36%-153.45K | -185.13%-52.52K | -9.12%537.72K | -135.49%-382.43K | -83.08%221.22K | 113.28%61.7K | -79.89%591.67K | -70.21%1.08M |
| Total composite income | 109.28%7.08M | 146.91%48.12M | 142.21%45.6M | 120.23%38.89M | -178.70%-76.34M | -152.78%-102.59M | -143.07%-108.04M | -331,112.04%-192.28M | -52.82%97M | -23.42%194.36M |
| Total composite income of parent company owners | 120.29%13.86M | 152.17%51.43M | 145.40%47.63M | 120.95%39.92M | -166.00%-68.32M | -149.89%-98.58M | -141.48%-104.93M | -53,118.56%-190.56M | -50.16%103.51M | -22.88%197.6M |
| Total composite income of minority owners | 15.46%-6.78M | 17.43%-3.31M | 34.73%-2.03M | 40.69%-1.03M | -23.21%-8.02M | -23.70%-4.01M | -46.93%-3.11M | -314.00%-1.73M | -212.23%-6.51M | -32.65%-3.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm